Research halted on rimonabantSanofi-Aventis has discontinued further development of rimonabant for all therapeutic indications. Pharmacy's night of starsA veritable Who's Who of the pharmacy industry gathered at Toronto's Fairmont Royal York hotel on November 17th for Commitment to Care and Service Awards. Experts gather to discuss patient adherence Experts from across the health profession gathered for a two-day conference in Toronto from November 6-7 for the Strategy Institute's Spending on drugs leads health expenditure growth New figures released by the Canadian Institute for Health Information indicate Canada's healthcare spending will hit $171.9 billion this year, an increase of 6.4% over 2007. Canada lands 10th on international health indicators comparison Insulin still under-prescribed by family doctors for type 2 diabetes Forty per cent of patients in study not reaching blood glucose targets Clinical in Brief - Nov 11/08 LETTER: Pharma needs to be more upfront about drug risks Staging system individualizes best kidney CA therapy Risk of recurrence can be used to spare some from harsh treatments, target others at risk More discussion with families needed on glucocorticoid side-effects in kids First Previous 2487 2488 2489 2490 2491 Next Last
